Sitaglu

Sitagliptin, commonly known as Sitaglu, is a medication used to manage type 2 diabetes. It works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which helps to increase the levels of incretin hormones. These hormones stimulate the pancreas to release more insulin and reduce the production of glucagon, a hormone that raises blood sugar levels. By balancing insulin and glucagon, Sitagliptin helps to control blood sugar levels, making it easier to manage diabetes.

Sitagliptin is typically taken orally and is available in various brand names, including Januvia and Zituvio. It is often prescribed in combination with other medications like metformin or ertugliflozin to enhance its effectiveness. The medication is not suitable for patients with type 1 diabetes or those who have a history of pancreatitis.

When taken as directed, Sitagliptin can significantly reduce fasting and postmeal blood glucose levels. This, in turn, helps to lower the overall glycemic control, as measured by glycosylated hemoglobin (HbA1c) levels. Sitagliptin is 87% orally bioavailable and reaches its maximum plasma concentration within two hours, making it a convenient addition to your daily routine.

By enhancing insulin secretion and reducing glucagon levels, Sitagliptin helps to improve glycemic control, making it easier to manage the symptoms of type 2 diabetes. Always consult with your healthcare provider before starting any new medication regimen.